Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze APLS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate APLS investment potential.

What is APLS stock price today?

Get real-time APLS stock price, historical data, and price charts on Financhill. Track APLS performance with our advanced analysis tools.

Is APLS a good investment?

Evaluate APLS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy APLS stock?

To buy APLS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of APLS?

View detailed market capitalization data and company valuation metrics for APLS on our comprehensive analysis page.

What is the P/E ratio of APLS?

Use our fundamental analysis tools to view APLS P/E ratio and compare valuation metrics with industry peers.

What are APLS earnings?

View APLS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Apellis Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

APLS
Apellis Pharmaceuticals, Inc.

Last Price:

$22.81

Seasonality Move:

5.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Apellis Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 19.8% based on the past 8 years of stock performance.
Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Apellis Pharmaceuticals, Inc. Stock Undervalued?

The current Apellis Pharmaceuticals, Inc. [APLS] share price is $22.80. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Apellis Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Apellis Pharmaceuticals, Inc. has on average historically risen by 19.8% based on the past 8 years of stock performance.

Apellis Pharmaceuticals, Inc. Stock Rating

Sell

Apellis Pharmaceuticals, Inc. (APLS) is a Sell

Is Apellis Pharmaceuticals, Inc. overpriced?

Apellis Pharmaceuticals, Inc. has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Apellis Pharmaceuticals, Inc. Stock Price History

Is APLS stock going to rise?

The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

apellis.com

52-Week Data

52-Week High:

30.48

52-Week Low:

16.10

Prediction Charts

Market Cap:

2.9B

Price in USD:

22.80

Volume:

Beta:

0.87

Technical Analysis

SMA50:

23.43

SMA100:

23.17

SMA200:

22.22

52-Wk Change:

-19.69%

Stock Predictions

Is Apellis Pharmaceuticals, Inc. stock public?

Yes, Apellis Pharmaceuticals, Inc. is a publicly traded company.
What is the Apellis Pharmaceuticals, Inc. stock quote today?

The Apellis Pharmaceuticals, Inc. stock price is 22.80 USD today.
How to buy Apellis Pharmaceuticals, Inc. stock online?

You can buy Apellis Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-30	22.96	22.58	23.42	21.80
Feb-2	22.04	22.83	23.39	21.59
Feb-3	22.50	23.32	23.93	22.50
Feb-4	23.32	23.15	23.44	22.69
Feb-5	23.31	22.56	24.10	22.29
Feb-6	22.68	23.49	23.58	22.57
Feb-9	22.94	22.83	23.69	22.70
Feb-10	23.12	22.58	23.18	22.51
Feb-11	22.46	22.31	22.50	21.71
Feb-12	22.23	22.05	22.38	21.72
Feb-13	22.05	21.70	22.55	21.54
Feb-17	21.68	21.57	21.93	21.30
Feb-18	21.59	22.20	22.41	21.59
Feb-19	22.05	22.80	22.81	21.64

Apellis Pharmaceuticals, Inc. Earnings

Apellis Pharmaceuticals, Inc. Earnings Report: Per Share Apellis Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Apellis Pharmaceuticals, Inc. Forecast Revenue Growth

Apellis Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $1.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.89 per share.

* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.